Prospective Study for Molecular Biomarkers of Normal Nasopharyngeal Tissue

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03048305

Enrollment

200

Registered

2017-02-09

Start date

2017-02-01

Completion date

2023-01-31

Last updated

2020-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal Carcinoma

Brief summary

The investigators collect nasopharyngeal epithelium samples from healthy individuals and analyze for biomarkers compared with tumor tissues from another clinical research project. The goal of this study is to identify molecular biomarkers for prediction of nasopharyngeal carcinoma.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Patients suspected of nasopharyngeal carcinoma but excluded by biopsy

Exclusion criteria

* Diagnosed as nasopharyngeal carcinoma during the follow-up period

Design outcomes

Primary

Measure	Time frame
the positive rate of risk signature in healthy individuals	3 years

Countries

China

Contacts

Primary ContactJun Ma, M.D.

majun2@mail.sysu.edu.cn+86-20-87343469

Outcome results